Ligand validation:4RFO

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4RFO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RFO_NAG_G_501	77%	54%	0.105	0.943	0.5	1.26	-	2	0	0	100%	1
4RFO_NAG_G_505	60%	27%	0.14	0.925	0.5	2.39	-	6	0	0	100%	1
4RFO_NAG_G_506	57%	55%	0.157	0.933	0.6	1.12	-	2	0	0	100%	1
4RFO_NAG_G_504	55%	43%	0.14	0.907	0.6	1.56	-	2	0	0	100%	1
4RFO_NAG_G_508	51%	47%	0.166	0.919	0.61	1.4	-	2	0	0	100%	1
4RFO_NAG_G_503	37%	14%	0.209	0.909	0.98	2.8	1	4	2	0	100%	1
4RFO_NAG_G_502	27%	56%	0.256	0.907	0.57	1.13	-	2	0	0	100%	1
4RFO_NAG_G_509	23%	46%	0.264	0.887	0.78	1.29	1	3	0	0	100%	1
4RFO_NAG_G_507	22%	57%	0.318	0.936	0.57	1.07	-	2	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
7SX7_NAG_G_502	100%	62%	0.032	0.985	0.67	0.78	-	-	0	0	100%	1
7SX6_NAG_G_504	100%	85%	0.035	0.987	0.21	0.52	-	-	0	0	100%	1
4YFL_NAG_E_507	98%	70%	0.061	0.985	0.48	0.66	-	-	0	0	100%	1
3SE8_NAG_G_734	94%	68%	0.063	0.961	0.56	0.68	-	-	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1
7DDF_NAG_B_401	100%	87%	0.02	0.992	0.21	0.47	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.